Ameritas Investment Partners, Inc.
Position in CADL — Candel Therapeutics, Inc.
CIK 1055980
LINCOLN, NE
Position in CADL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$19,678
-$3,012 QoQ
Shares Held
4,016
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ameritas Investment Partners, Inc. holds $51,201,821 across 216 Biotechnology names. CADL ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,563 | $5,609,881 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,656 | $3,597,411 | |
| 3 | EXEL |
Exelixis, Inc.
|
70,554 | $3,026,060 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
36,974 | $2,318,269 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,300,872 | |
| 6 | CYTK |
Cytokinetics Inc
|
32,284 | $2,127,838 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
11,194 | $2,116,225 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
35,392 | $1,999,294 |
All Filings in CADL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,678 | 4,016 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $22,690 | 4,016 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $20,481 | 4,016 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $20,320 | 4,016 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $10,966 | 1,941 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $16,847 | 1,941 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $13,451 | 1,941 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $12,034 | 1,941 | Shares | Other | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||